Wild

wildbio.tech

Wild Biotech Ltd. is a pioneering drug discovery platform that leverages evolutionary adaptations from the animal kingdom to develop novel miniprotein and peptide therapeutics. Utilizing a unique database with over 200 million microbial genes, the company employs advanced machine learning and synthetic biology techniques to identify and validate bioactive molecules. Their innovative approach targets unmet clinical needs in immune and cardiometabolic disorders, with multiple candidates progressing towards drug development phases, aiming for significant milestones in human clinical trials. Wild's differentiation lies in its extensive biodiversity research and proprietary structural catalog, positioning it as a leader in the therapeutic landscape.

Is this your company?